3-Bromo-4-chlorobenzotrifluoride | CAS:454-78-4 99.0% bulk supply

We serve 3-Bromo-4-chlorobenzotrifluoride CAS:454-78-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Chemical Name: 3-Bromo-4-chlorobenzotrifluoride

CAS.NO:454-78-4

Synonyms:2-bromo-1-chloro-4-(trifluoromethyl)benzene;

3-Bromo-4-chloro-α,α,α-trifluorotoluene;

3-BroMo-4-chlorobenzotrifluoride;

Molecular Formula: C7H3BrClF3

Molecular Weight:259.45100

Physical and Chemical Properties:

Density:1.726g/cm3

Melting point:−23-−22 °C(lit.)

Boiling point:188-190 °C(lit.)

Flash point:202 °F

Index of Refraction:1.499

Specification:

Appearance:Clear Pale Yellow Liquid

Purity:≥99.0%

Packing:50g 100g per small packet or as customer request

Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Application: Applicationd as Pharmaceutical intermediates

Contact us for information like 3-Bromo-4-chlorobenzotrifluoride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-BroMo-4-chlorobenzotrifluoride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-BroMo-4-chlorobenzotrifluoride Use and application,3-Bromo-4-chlorobenzotrifluoride technical grade,usp/ep/jp grade.

Related News: For example, an active ingredient to relieve pain is included in a painkiller.2,3,4,6-tetra-O-acetyl-D-glucono-1,5-lactone manufacturer At the same time, because the profits of a single variety of characteristic APIs do not have long-term growth, companies need more product reserves.1,3,5-Tri-O-benzoyl-D-ribofuranose supplier If the drug is in a syrup form, then the excipient is the liquid that has been used to make it as such.Diallylamine vendor A key publication in a preclinical model demonstrated rigosertib’s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: “A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.” Cell 165, 643).The best you can do is take medicines and treatments for specific symptoms.